Recent News for ONCS - OncoSec Medical Incorporated

Date Title
Feb 11 OncoSec Strengthens its Board of Directors with Three New Appointments
Feb 10 OncoSec Announces Closing of the CGP/Sirtex Transaction
Feb 10 95 Biggest Movers From Friday
Feb 7 OncoSec Announces that Shareholders Have Approved CGP/Sirtex Transaction
Feb 7 OncoSec Announces that Nevada Court Denies Alpha Holdings’ Motion to Enjoin Special Meeting of Shareholders
Feb 4 Clinical Cancer Research highlights OncoSec's Merkel Cell Carcinoma Clinical Study on the Cover of its February Issue
Feb 3 Alpha Holdings Urges OncoSec Stockholders to Vote Against China Grand Takeover on BLUE Proxy Card Only
Feb 3 OncoSec's Visceral Lesion Applicator (VLA) Electroporation Device Demonstrates Targeted Entry and Deployment in Both Lung and Liver in Data Presented at the Society of Interventional Oncology Annual Meeting
Jan 31 OncoSec Urges Shareholders to Focus on the Critical Benefits of CGP/Sirtex Transaction
Jan 28 OncoSec Urges Shareholders Not to Fall for Alpha’s Disingenuous "Proposal" and Scheme to Prevent Fair Vote at Special Meeting
Jan 27 PLG, AIM, INO and ONCS among midday movers
Jan 27 Alpha Holdings Renews Superior, $39.3 Million Offer to OncoSec
Jan 27 Data from OncoSec's Visceral Lesion Applicator (VLA) to be Presented at the Society of Interventional Oncology Annual Meeting
Jan 21 OncoSec Announces the Appointment of Robert J. DelAversano, C.P.A, as Principal Accounting Officer and Controller
Jan 21 OncoSec Sends Letter Urging Shareholders Not to Be Distracted by Alpha’s Last-Ditch Efforts to Derail CGP/Sirtex Transaction
Jan 17 Alpha Holdings Comments on OncoSec’s Failure to Consider Superior Financing Proposal
Jan 16 OncoSec Board Rejects Alpha Holdings "Proposal" and Announces New Special Meeting Date
Jan 15 INSERTING and REPLACING Alpha Holdings Sends Open Letter to OncoSec Stockholders Answering Questions on Proposed Financing
Jan 14 BYND, FCEL among premarket gainers
Jan 14 Alpha Holdings Makes Superior, $39.3 Million Offer to OncoSec
Jan 7 Alpha Holdings Urges Oncosec Stockholders to Vote Against China Grand Takeover on Blue Proxy Card
Jan 6 OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms – ISS and Glass Lewis – Have Recommended That OncoSec Shareholders Vote "FOR" the CGP/Sirtex Transaction on the WHITE Proxy Card
Dec 30 Alpha Holdings Highlights Benefits of Its Alternate Financing Proposal for OncoSec
Dec 26 OncoSec's advisory firm backs CGP/Sirtex transaction
Dec 26 Alpha Holdings Comments on ISS Report

Back to the Main ONCS Page...